Middle Molecule Find

Rulebook › V-tags › V551

V551 Plan: monitoring the access

Written V0551 on the CMS-2567 and in QCOR.

Enforces 42 CFR 494.90(a)(5) · Appendix H Rev. 246, page 236 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

§ 494.90(a) Standard: Development of patient plan of care. …The plan of care must address, but not be limited to, the following: (5) Vascular access…. The patient’s vascular access must be monitored to prevent access failure, including monitoring of arteriovenous grafts and fistulae for symptoms of stenosis.

Read 42 CFR 494.90 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.90(a)(5)

Note: this guidance is a continuation of the regulatory requirement at § 494.90(a)(5).

The facility must have an ongoing program for vascular access monitoring and surveillance to detect failure early and facilitate timely referral of patients for intervention when indications of significant stenosis are present. Patient education should address self-monitoring of the vascular access.

Monitoring strategies may include physical examination of the vascular access, observation of changes in adequacy or pressures measured during dialysis, difficulties with cannulation, or challenges in achieving hemostasis. Precipitating events should also be noted, such as hypotension or hypovolemia. Surveillance strategies include device-based methods, such as access flow measurements, direct or derived static venous pressure ratios, and duplex ultrasound.

For patients with grafts and fistulas, the medical record should show evidence of periodic monitoring and surveillance of the vascular access for stenosis and signs of impending failure. The documentation of this may be on the dialysis treatment record, progress notes, or on a separate log. A member of the facility staff must review the vascular access monitoring/surveillance documentation to identify adverse trends and act if indicated.

Refer to the Conditions for Infection Control at V147 and V148, as well as the Condition for QAPI at V633, which also cover the monitoring and surveillance of vascular accesses.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 236 (the full 469-page PDF) before quoting it.

Connected tags

Tags whose guidance points here